HOME >> BIOLOGY >> NEWS
Blood markers associated with autism and mental retardation

ervices. This archive of newborn blood specimens is an incredible treasure, providing a tremendously valuable resource for scientific study of a wide range of developmental disabilities and birth defects.

Neural growth factors are important to the formation of the central nervous system during embryonic development. Previous research shows that many of these growth factors play a vital role in the production of new brain cells and the organization of those cells into distinct networks. The investigators hypothesize that an abnormal abundance of these proteins may disrupt the normal process of cell migration, differentiation, and programmed death during early nervous system development. Animal studies have shown that an early shortage of one of these proteins leads to microcephaly and other developmental problems.

The investigators speculate that a breakdown in the regulation of factors that influence early brain development is important in autism and mental retardation. Since these disorders cannot be clinically diagnosed until later in childhood, the identification of molecular markers could be helpful in the early diagnosis of the disorders and in the design of future clinical studies to test therapies. The researchers plan to continue their work to further elucidate the biological and genetic mechanisms that underlie the development of autism and other developmental disorders.

Autism is a pervasive developmental disorder that affects approximately 10 to 20 people in every 10,000 and affects males about four times more frequently than females. Symptoms of autism may surface in children around the age of 2. People with classical autism show three types of symptoms: impaired social interaction, problems with verbal and nonverbal communication, and unusual or severely limited activities and interests. People with autism may also show abnormal responses to sensory stimuli, such as touch, sounds, and sights. Twin studies suggest that autism has a
'"/>

Contact: Marcia Vital or Paul Girolami
301-496-5751
NIH/National Institute of Neurological Disorders and Stroke
24-Apr-2001


Page: 1 2 3

Related biology news :

1. Blood pressure hormone may inhibit growth of lung cancer
2. Blood tests identify patients on dialysis at high risk for death from cardiovascular disease
3. Blood banking systems improving in China, more progress needed
4. Blood proteins tied to inflammation
5. Bloodworms way with copper likely provides paradigm for new materials
6. Blood markers may reflect newborns potential of contracting HIV
7. Blood stem cells carry targeted genes
8. Blood vessels trigger development of the pancreas
9. Blood vessels found to signal chain of destruction in bone diseases
10. Blood test for diagnosing schizophrenia
11. Blood pressure-lowering DASH diet also reduces homocysteine

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/22/2016)... 22, 2016   Acuant , the ... solutions, has partnered with RightCrowd ® ... Visitor Management, Self-Service Kiosks and Continuous Workforce ... add functional enhancements to existing physical access ... venues with an automated ID verification and ...
(Date:6/15/2016)... , June 15, 2016 ... report titled "Gesture Recognition Market by Application Market - Global Industry ... - 2024". According to the report, the  global gesture ... in 2015 and is estimated to grow at ... billion by 2024.  Increasing application of ...
(Date:6/2/2016)... , June 2, 2016 The ... has awarded the 44 million US Dollar project, for ... Embossed Vehicle Plates including Personalization, Enrolment, and IT Infrastructure ... leader in the production and implementation of Identity Management Solutions. ... January, however Decatur was selected for ...
Breaking Biology News(10 mins):
(Date:12/2/2016)... THOUSAND OAKS, Calif. , Dec. 2, 2016 ... AGN ) today announced the submission of a ... for ABP 215, a biosimilar candidate to Avastin ® ... biosimilar application submitted to the EMA. "The ... milestone as Amgen seeks to expand our oncology portfolio," said ...
(Date:12/2/2016)... (PRWEB) , ... December 01, 2016 , ... ACEA Biosciences, ... its Phase I/II clinical trials for AC0010 at the World Conference on Lung Cancer ... providing an update on the phase I/II clinical trials for AC0010 in patients with ...
(Date:12/2/2016)... ... 01, 2016 , ... PhUSE will build on the huge ... Single Day Events (SDE) to organize a multiple-day US conference. The first annual ... of the pharmaceutical and life sciences industry will cover industry standards, data science, ...
(Date:12/2/2016)... ... 01, 2016 , ... Orthogonal, a Chicago-based medical device software ... II 510(k) clearance for their flagship medical device, SimplECG. , With this FDA ... that rely on cloth-based nanosensors. While other companies have attempted to focus on ...
Breaking Biology Technology:
Cached News: